Poly Medicure Limited Share Price NSE India S.E.
Equities
POLYMED
INE205C01021
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,899.10 INR | -0.61% |
|
-2.06% | -27.38% |
| 11/11 | Poly Medicure Limited, Q2 2026 Earnings Call, Nov 10, 2025 | |
| 10/11 | Poly Medicure Limited Provides Earnings Guidance for the Second Half of 2026 | CI |
| Capitalization | 19TCr 213.94Cr 183.9Cr 172.28Cr 160.57Cr 296.59Cr 322.6Cr 2.02TCr 778.05Cr 9.09TCr 802.96Cr 785.82Cr 33TCr | P/E ratio 2026 * |
51.6x | P/E ratio 2027 * | 41.8x |
|---|---|---|---|---|---|
| Enterprise value | 18TCr 201.57Cr 173.27Cr 162.32Cr 151.29Cr 279.44Cr 303.95Cr 1.9TCr 733.07Cr 8.57TCr 756.53Cr 740.38Cr 31TCr | EV / Sales 2026 * |
9.51x | EV / Sales 2027 * | 7.69x |
| Free-Float |
32.64% | Yield 2026 * |
0.26% | Yield 2027 * | 0.33% |
Last Transcript: Poly Medicure Limited
| 1 day | -0.61% | ||
| 1 week | -2.06% | ||
| Current month | -2.06% | ||
| 1 month | +0.28% | ||
| 3 months | -6.99% | ||
| 6 months | -14.95% | ||
| Current year | -27.38% |
| 1 week | 1,880 |  | 1,939.9 |
| 1 month | 1,832.9 | | 2,094.3 |
| Current year | 1,821.2 | | 2,937.6 |
| 1 year | 1,821.2 | | 3,031 |
| 3 years | 820.3 | | 3,357.8 |
| 5 years | 449.25 | | 3,357.8 |
| 10 years | 117 | | 3,357.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Himanshu Baid
CEO | Chief Executive Officer | 57 | 13/01/2010 |
| Director of Finance/CFO | - | 01/07/2021 | |
| Chief Operating Officer | 58 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 88 | 26/05/2005 | |
| Director/Board Member | 83 | 13/01/2010 | |
Rishi Baid
BRD | Director/Board Member | 53 | 30/03/1995 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.61% | -2.06% | - | - | 213.94Cr | |
| -0.26% | -2.96% | +8.20% | +19.34% | 22TCr | |
| -0.62% | -3.77% | +20.65% | +31.79% | 13TCr | |
| +0.60% | -7.93% | +39.54% | +99.46% | 6.59TCr | |
| +0.10% | -0.03% | -11.84% | -21.31% | 5.54TCr | |
| +0.88% | +4.51% | +18.97% | +79.93% | 5.2TCr | |
| +0.87% | -1.13% | +21.95% | +41.88% | 2.58TCr | |
| +0.37% | +3.18% | -15.74% | -44.46% | 2.55TCr | |
| -0.33% | +2.89% | +18.63% | -32.99% | 2.41TCr | |
| +0.49% | -0.50% | -22.80% | +21.69% | 2.25TCr | |
| Average | +0.14% | -1.19% | +8.62% | +21.70% | 6.87TCr | |
| Weighted average by Cap. | -0.02% | -2.43% | +12.13% | +28.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.91TCr 21Cr 18Cr 17Cr 16Cr 29Cr 32Cr 199.63Cr 77Cr 900.89Cr 80Cr 78Cr 3.29TCr | 2.35TCr 26Cr 22Cr 21Cr 20Cr 36Cr 39Cr 245.62Cr 95Cr 1.11TCr 98Cr 96Cr 4.05TCr |
| Net income | 368.12Cr 4.09Cr 3.52Cr 3.29Cr 3.07Cr 5.67Cr 6.17Cr 39Cr 15Cr 173.86Cr 15Cr 15Cr 635.7Cr | 455.95Cr 5.07Cr 4.35Cr 4.08Cr 3.8Cr 7.02Cr 7.64Cr 48Cr 18Cr 215.34Cr 19Cr 19Cr 787.37Cr |
| Net Debt | -1.11TCr -12Cr -11Cr -9.96Cr -9.28Cr -17Cr -19Cr -116.51Cr -45Cr -525.8Cr -46Cr -45Cr -1.92TCr | -1.21TCr -13Cr -12Cr -11Cr -10Cr -19Cr -20Cr -126.68Cr -49Cr -571.66Cr -50Cr -49Cr -2.09TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/25/05 | 1,899.10 ₹ | -0.61% | 51,575 |
| 04/25/04 | 1,910.80 ₹ | -0.32% | 56,275 |
| 03/25/03 | 1,916.90 ₹ | -0.43% | 55,449 |
| 02/25/02 | 1,925.20 ₹ | -0.35% | 1,19,358 |
| 01/25/01 | 1,932.00 ₹ | -0.37% | 44,758 |
Delayed Quote NSE India S.E., December 05, 2025 at 05:19 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- POLYMED Stock
- POLYMED Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition